Humira Buyers Ask 7th Circ. To Revive 'Patent Thicket' Case
Humira buyers have urged the Seventh Circuit to revive their suit claiming AbbVie built an anti-competitive "patent thicket" around its blockbuster immunosuppressant drug Humira to keep cheaper biosimilars from coming to...To view the full article, register now.
Already a subscriber? Click here to view full article